Liminatus Pharma, Inc. LIMN
2.63 USD -0.16 (-5.88%)
At closeNov 5, 2026, 5:40 PM EST
2.60 -0.03 -1.14%
After hours · Nov 5, 5:40 PM ET
2.60 Day range 3.07
2.40 52-week range 141.50
- YTD
- -91.38%
- 1 year
- -95.98%
- Market cap
- 3.53M
- EPS (ttm)
- -22.12
- YTD return
- -91.38%
- 1-year return
- -95.98%
- Volume
- 104.74K
- Avg volume
- 214.26K
- Open
- 2.91
- Previous close
- 2.79
- Day's range
- 2.60 – 3.07
- 52-week range
- 2.40 – 141.50
2Y -399.36 (-99.34%)
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule 
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
Liminatus Pharma Engages Synex Consulting To Support Clinical Development Of IBC101, CD19xCD22 Bivalent CAR-T Cell Therapy Candidate 
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Liminatus Pharma Board Adopts Resolutions Approving Reverse Stock Split Of Its Common Stock At Ratio Of 1-For-50 
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock - 12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.